Neuroprotective effects of combination therapy with tirilazad and magnesium in rats subjected to reversible focal cerebral ischemia

Neurosurgery

Volumn 44, Issue 1, 1999, Pages 163-172

  Schmid Elsaesser, Robert ^a   Zausinger, Stefan ^a   Hungerhuber, Edwin ^a   Baethmann, Alexander ^a   Reulen, Hans Juergen ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Cerebral ischemia; Cerebral protection; Cerebrovascular surgery; Magnesium; Tirilazad mesylate

Indexed keywords

MAGNESIUM CHLORIDE; TIRILAZAD;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN INFARCTION; BRAIN ISCHEMIA; BRAIN PROTECTION; CONTROLLED STUDY; DRUG EFFECT; DRUG MIXTURE; DRUG SCREENING; LASER DOPPLER FLOWMETRY; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; CEREBRAL CORTEX; CEREBRAL INFARCTION; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; EXCITATORY AMINO ACID ANTAGONISTS; FREE RADICAL SCAVENGERS; ISCHEMIC ATTACK, TRANSIENT; LASER-DOPPLER FLOWMETRY; MAGNESIUM CHLORIDE; MALE; NEUROLOGIC EXAMINATION; NEUROPROTECTIVE AGENTS; PREGNATRIENES; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0032904206     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006123-199901000-00100     Document Type: Article

References (81)

1. Albers GW, Atkinson RP, Kelley RE, Rosenbaum DM: Safety, tolerability, and pharmacokinetics of the N-methyl-D-aspartate antagonist dextrorphan in patients with acute stroke. Stroke 26: 254-258, 1995.
2. Altura BM, Altura BT: Pharmacologic inhibition of cerebral vasospasm in ischemia, hallucinogen ingestion, and hypomagnesemia: Barbiturates, calcium antagonists, and magnesium. Am J Emerg Med 1:180-190, 1983.
3. Altura BT, Altura BM: Interactions of Mg and K on cerebral vessels: Aspects in view of stroke - Review of present status and new findings. Magnesium 3:195-211, 1984.
4. Armstead WM, Mirro R, Thelin OP, Shibata M, Zuckerman SL, Shanklin DR, Busija DW, Leffler CW: Polyethylene glycol superoxide dismutase and catalase attenuate increased blood brain barrier permeability after ischemia in piglets. Stroke 23:755-762, 1992.
5. Aspey BS, Alp MS, Patel Y, Harrison MJ: Effects of combined glutamate and platelet-activating factor inhibition on the outcome of focal cerebral ischaemia: An initial screening study. Metab Brain Dis 12:237-249, 1997.
6. Auer RN: Combination therapy with U74006F (tirilazad mesylate), MK-801, insulin and diazepam in transient forebrain ischaemia. Neurol Res 17:132-136, 1995.
7. Barth A, Barth L, Newell DW: Combination therapy with MK-801 and alpha-phenyl-tert-butyl-nitrone enhances protection against ischemic neuronal damage in organotypic hippocampal slice cultures. Exp Neurol 141:330-336, 1996.
8. Bederson JB, Germano IM, Guarino L: Cortical blood flow and cerebral perfusion pressure in a new noncraniotomy model of subarachnoid hemorrhage in the rat. Stroke 26:1086-1091, 1995.
9. Bederson JB, Pitts LH, Tsuji M, Nishimura MC, Davis RL, Bartkowski H: Rat middle cerebral artery occlusion: Evaluation of the model and development of a neurologic examination. Stroke 17:472-476, 1986.
10. Belayev L, Alonso OF, Busto R, Zhao W, Ginsberg MD: Middle cerebral artery occlusion in the rat by intraluminal suture: Neurological and pathological evaluation of an improved model. Stroke 27:1616-1623, 1996.
11. Belfort MA, Moise KJ Jr: Effect of magnesium sulfate on maternal brain blood flow in preeclampsia: A randomized, placebo-controlled study. Am J Obstet Gynecol 167:661-666, 1992.
12. Blair JL, Warner DS, Todd MM: Effects of elevated plasma magnesium versus calcium on cerebral ischemic injury in rats. Stroke 20:507-512, 1989.
13. Braughler JM, Hall ED, Jacobsen EJ, McCall JM, Means ED: The 21-aminosteroids: Potent inhibitors of lipid peroxidation for the treatment of central nervous system trauma and ischemia. Drugs Future 14:143-152, 1989.
14. Chi OZ, Pollak P, Weiss HR: Effects of magnesium sulfate and nifedipine on regional cerebral blood flow during middle cerebral artery ligation in the rat. Arch Int Pharmacodyn Ther 304:196-205, 1990.
15. Choi DW: Excitotoxic cell death. J Neurobiol 23:1261-1276, 1992.
16. Davis S, Helfaer MA, Traystman RJ, Hurn PD: Parallel antioxidant and antiexcitotoxic therapy improves outcome after incomplete global cerebral ischemia in dogs. Stroke 28:198-204, 1997.
17. de Courten-Myers GM, Myers RE, Schoolfield L: Hyperglycemia enlarges infarct size in cerebrovascular occlusion in cats. Stroke 19:623-630, 1988.
18. Feldman Z, Gurevitch B, Artru AA, Oppenheim A, Shohami E, Reichenthal E, Shapira Y: Effect of magnesium given 1 hour after head trauma on brain edema and neurological outcome. J Neurosurg 85:131-137, 1996.
19. Ghribi O, Callebert J, Verrecchia C, Plotkine M, Boulu RG: Blockers of NMDA-operated channels decrease glutamate and aspartate extracellular accumulation in striatum during forebrain ischaemia in rats. Fundam Clin Pharmacol 9:141-146, 1995.
20. Gill R: The pharmacology of a-Amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA)/Kainate antagonists and their role in cerebral ischemia. Cerebrovasc Brain Metab Rev 6:225-256, 1994.
21. Ginsberg MD, Globus MYT, Dietrich WD, Busto R: Temperature modulation of ischemic brain injury: A synthesis of recent advances. Prog Brain Res 96:13-22, 1993.
22. Grotta J, Clark W, Coull B, Pettigrew LC, Mackay B, Goldstein LB, Meissner I, Murphy D, Larue L: Safety and tolerability of the glutamate antagonist CGS 19755 (Selfotel) in patients with acute ischemic stroke: Results of a phase IIa randomized trial. Stroke 26:602-605, 1995.
23. Hall ED: Inhibition of lipid peroxidation in central nervous system trauma and ischemia. J Neurol Sci 134[Suppl]:79-83, 1995.
24. Hall ED, Yonkers PA: Attenuation of postischemic cerebral hypoperfusion by the 21-aminosteroid U74006F. Stroke 19:340-344, 1988.
25. Hall ED, McCall JM, Means ED: Therapeutic potential of the lazaroids (21-aminosteroids) in acute central nervous system trauma, ischemia and subarachnoid hemorrhage. Adv Pharmacol 28:221-268, 1994.
26. Helfaer MA, Kirsch JR, Haun SE, Moore LE, Traystman RJ: Polyethylene glycol-conjugated superoxide dismutase fails to blunt postischemic reactive hyperemia. Am J Physiol 261:H548-H553, 1991.
27. 2+ protects against PCP-induced cerebrovasospasms and vascular damage in rat brain. Magnes Trace Elem 9:44-46, 1990.
28. Iseri LT, French JH: Magnesium: Nature's physiologic calcium blocker. Am Heart J 108:188-193, 1984.
29. Izumi Y, Roussel S, Pinard E, Seylaz J: Reduction of infarct volume by magnesium after middle cerebral artery occlusion in rats. J Cereb Blood Flow Metab 11:1025-1030, 1991.
30. Karibe H, Chen J, Zarow GJ, Graham SH, Weinstein PR: Delayed induction of mild hypothermia to reduce infarct volume after temporary middle cerebral artery occlusion in rats. J Neurosurg 80:112-119, 1994.
31. Karlsson BR, Loberg EM, Grogaard B, Steen PA: The antioxidant tirilazad does not affect cerebral blood flow or histopathologic changes following severe ischemia in rats. Acta Neurol Scand 90:256-262, 1994.
32. Kass IS, Cottrell JE, Chambers G: Magnesium and cobalt, not nimodipine, protect neurons against anoxic damage in the rat hippocampal slice. Anesthesiology 69:710-715, 1988.
33. Kassell NF, Haley EC, Apperson-Hansen C, Stat M, Alves WM, Dorsch NW, Fabinyi G, Matheson J, Reilly P, Siu K, Stokes B, Stuart G, Koos W, Calliauw L, Selosse P, Astrup J, Gjerris F, Mendelow AD, Castel JP, Christiaens JL, Cophignon J, Keravel Y, Lagarrigue J, Mourier K, Philippon J, Brandt L, Vonessen C, Persson L, Brock M, Fahlbusch P, Gilsbach J, Hassler W, Perneczky A, Samii M, Schmiedek P, Mee E, Arista A, Cantore G, Carteri A, Collice M, Dapian R, Marini G, Menonna P, Baena RRY, Matteo PS, Testa PC, Villani R, Antunes JL: Randomized, double-blind, vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage: A cooperative study in Europe, Australia, and New Zealand. J Neurosurg 84:221-228, 1996.
34. Koizumi J, Yoshida Y, Nakazawa T, Ooneda G: Experimental studies of ischemic brain edema: 1 - A new experimental model of cerebral embolism in rats in which recirculation can be introduced in the ischemic area. Jpn J Stroke 8:1-8, 1986.
35. Marie C, Bralet J: Blood glucose level and morphological brain damage following cerebral ischemia. Cerebrovasc Brain Metab Rev 3:29-38, 1991.
36. Marinov MB, Harbaugh KS, Hoopes PJ, Pikus HJ, Harbaugh RE: Neuroprotective effects of preischemia intraarterial magnesium sulfate in reversible focal cerebral ischemia. J Neurosurg 85:117-124, 1996.
37. Maruki Y, Koehler RC, Kirsch JR, Blizzard KK, Traystman RJ: Tirilazad pretreatment improves early cerebral metabolic and blood flow recovery from hyperglycemic ischemia. J Cereb Blood Flow Metab 15:88-96, 1995.
38. McIntosh TK, Vink R, Yamakami I, Faden AI: Magnesium protects against neurological deficit after brain injury. Brain Res 482:252-260, 1989.
39. McLean RM: Magnesium and its therapeutic uses: A review. Am J Med 96:63-76, 1994.
40. Memezawa H, Zhao Q, Smith ML, Siesjö BK: Hyperthermia nullifies the ameliorating effect of dizocilpine maleate (MK-801) in focal cerebral ischemia. Brain Res 670:48-52, 1995.
41. Muir KW, Lees KR: A randomized, double-blind, placebo-controlled pilot trial of intravenous magnesium sulfate in acute stroke. Stroke 26:1183-1188, 1995.
42. Muir KW, Lees KR: Clinical experience with excitatory amino acid antagonist drugs. Stroke 26:503-513, 1995.
43. Müller TB, Haraldseth O, Jones RA, Sebastiani G, Lindboe CF, Unsgard G, Oksendal AN: Perfusion and diffusion-weighted MR imaging for in vivo evaluation of treatment with U74389G in a rat stroke model. Stroke 26:1453-1458, 1995.
44. Müller TB, Haraldseth O, Unsgard G: Characterization of the microcirculation during ischemia and reperfusion in the penumbra of a rat model of temporary middle cerebral artery occlusion: A laser Doppler flowmetry study. Int J Microcirc Clin Exp 14: 289-295, 1994.
45. Nishio A, Gebrewold A, Altura BT, Altura BM: Comparative effects of magnesium salts on reactivity of arterioles and venules to constrictor agents: An in situ study on microcirculation. J Pharmacol Exp Ther 246:859-865, 1988.
46. Nowak L, Bregestovski P, Ascher P, Herbet A, Prochiantz A: Magnesium gates glutamate-activated channels in mouse central neurones. Nature 307:462-465, 1984.
47. Ogilvy CS, Carter BS, Kaplan S, Rich C, Crowell RM: Temporary vessel occlusion for aneurysm surgery: Risk factors for stroke in patients protected by induced hypothermia and hypertension and intravenous mannitol administration. J Neurosurg 84:785-791, 1996.
48. Ogilvy CS, Chu D, Kaplan S: Mild hypothermia, hypertension, and mannitol are protective against infarction during experimental intracranial temporary vessel occlusion. Neurosurgery 38:1202-1209, 1996.
49. Olney JW, Labruyere J, Wang G, Wozniak DF, Price MT, Sesma MA: NMDA antagonist neurotoxicity: Mechanism and prevention. Science 254:1515-1518, 1991.
50. Park CK, Hall ED, Hwang JH, Kang JK, Choi CR: Postischemia treatment efficacy and dose-dependency of 21-Aminosteroid U-74006F in focal cerebral infarction. J Cereb Blood Flow Metab 13[Suppl 1]:S144, 1993 (abstr).
51. Pellegrini-Giampietro DE: Free radicals and the pathogenesis of neuronal death: Cooperative role of excitatory amino acids. Adv Exp Med Biol 366:59-71, 1994.
52. Pellegrino LJ: A Stereotaxic Atlas of the Rat Brain. New York, Plenum Press, 1979.
53. Persson L, Hardemark HG, Bolander HG, Hillered L, Olsson Y: Neurologic and neuropathologic outcome after middle cerebral artery occlusion in rats. Stroke 20:641-645, 1989.
54. Ram Z, Sadeh M, Shacked I, Sahar A, Hadani M: Magnesium sulfate reverses experimental delayed cerebral vasospasm after subarachnoid hemorrhage in rats. Stroke 22:922-927, 1991.
55. Robertson CS, Foltz R, Grossman RG, Goodman JC: Protection against experimental ischemic spinal cord injury. J Neurosurg 64:633-642, 1986.
56. Rogers DC, Campbell CA, Stretton JL, Mackay KB: Correlation between motor impairment and infarct volume after permanent and transient middle cerebral artery occlusion in the rat. Stroke 28:2060-2065, 1997.
57. Rothman S: Synaptic release of excitatory amino acid neurotransmitter mediates anoxic neuronal death. J Neurosci 4:1884-1891, 1984.
58. Rothman SM, Olney JW: Glutamate and the pathophysiology of hypoxic-ischemic brain damage. Ann Neurol 19:105-111, 1986.
59. Schanne FA, Gupta RK, Stanton PK: 31P-NMR study of transient ischemia in rat hippocampal slices in vitro. Biochim Biophys Acta 1158:257-263, 1993.
60. Schmid-Elsaesser R, Zausinger S, Hungerhuber E, Baethmann A, Reulen HJ: A critical reevaluation of the intraluminal thread model of focal cerebral ischemia: Evidence of inadvertent premature reperfusion and subarachnoid hemorrhage by laser Doppler flowmetry. Stroke 29:2162-2170, 1998.
61. Schmid-Elsaesser R, Zausinger S, Hungerhuber E, Plesnila N, Baethmann A, Reulen HJ: Superior neuroprotective efficacy of a novel antioxidant (U-101033E) with improved blood-brain barrier permeability in focal cerebral ischemia. Stroke 28:2018-2024, 1997.
62. Seelig JM, Wei EP, Kontos HA, Choi SC, Becker DP: Effect of changes in magnesium ion concentration on cat cerebral arterioles. Am J Physiol 43:H22-H26, 1983.
63. Siesjö BK: Historical overview: Calcium, ischemia, and death of brain cells. Ann N Y Acad Sci 522:638-661, 1988.
64. Siesjö BK: Pathophysiology and treatment of focal cerebral ischemia: Part I - Pathophysiology. J Neurosurg 77:169-184, 1992.
65. Siesjö BK: Pathophysiology and treatment of focal cerebral ischemia: Part II - Mechanisms of damage and treatment. J Neurosurg 77:337-354, 1992.
66. Siesjö BK, Agardh CD, Bengtsson F: Free radicals and brain damage. Cerebrovasc Brain Metab Rev 1:165-211, 1989.
67. Steinberg GK, Bell TE, Yenari MA: Dose escalation safety and tolerance study of the N-methyl-D-aspartate antagonist dextromethorphan in neurosurgery patients. J Neurosurg 84:860-866, 1996.
68. Taylor BM, Fleming WE, Benjamin CW, Wu Y, Mathews WR, Sun FF: The mechanism of cytoprotective action of lazaroids I: Inhibition of reactive oxygen species formation and lethal cell injury during periods of energy depletion. J Pharmacol Exp Ther 276: 1224-1231, 1996.
69. Thordstein M, Bagenholm R, Thiringer K, Kjellmer I: Scavengers of free oxygen radicals in combination with magnesium ameliorate perinatal hypoxic-ischemic brain damage in the rat. Pediatr Res 34:23-26, 1993.
70. Thurnau GR, Kemp DB, Jarvis A: Cerebrospinal fluid levels of magnesium in patients with preeclampsia after treatment with intravenous magnesium sulfate: A preliminary report. Am J Obstet Gynecol 157:1435-1438, 1987.
71. Traystman RJ, Kirsch JR, Koehler RC: Oxygen radical mechanisms of brain injury following ischemia and reperfusion. J Appl Physiol 71:1185-1195, 1991.
72. 2+ administered up to twenty-four hours following reperfusion prevents ischemic damage of the Ca1 neurons in the rat hippocampus. Neuroscience 44:335-341, 1991.
73. Tymianski M, Tator CH: Normal and abnormal calcium homeostasis in neurons: A basis for the pathophysiology of traumatic and ischemic central nervous system injury. Neurosurgery 38:1176-1195, 1996.
74. ++ protect against irreversible damage during CNS ischemia. Stroke 15:695-698, 1984.
75. Valtysson J, Hillered L, Andine P, Hagberg H, Persson L: Neuropathological endpoints in experimental stroke pharmacotherapy: The importance of both early and late evaluation. Acta Neurochir (Wien) 129:58-63, 1994.
76. Wahl F, Allix M, Plotkine M, Boulu RG: Neurological and behavioral outcomes of focal cerebral ischemia in rats. Stroke 23:267-272, 1992.
77. Warner DS, Takaoka S, Wu B, Ludwig PS, Pearlstein RD, Brinkhous AD, Dexter F: Electroencephalographic burst suppression is not required to elicit maximal neuroprotection from pentobarbital in a rat model of focal cerebral ischemia. Anesthesiology 84:1475-1484, 1996.
78. Wolf G, Keilhoff G, Fischer S, Hass P: Subcutaneously applied magnesium protects reliably against quinolinate-induced N-methyl-D-aspartate (NMDA)-mediated neurodegeneration and convulsions in rats: Are there therapeutical implications. Neurosci Lett 117:207-211, 1990.
79. Xue D, Slivka A, Buchan AM: Tirilazad reduces cortical infarction after transient but not permanent focal cerebral ischemia in rats. Stroke 23:894-899, 1992.
80. Zhao Q, Memezawa H, Smith ML, Siesjö BK: Hyperthermia complicates middle cerebral artery occlusion induced by an intraluminal filament. Brain Res 649:253-259, 1994.
81. Zhu CZ, Auer RN: Graded hypotension and MCA occlusion duration: Effect in transient focal ischemia. J Cereb Blood Flow Metab 15:980-988, 1995.